| Pamela J Smith, MD | |
|
25 Highland Ave, Newburyport, MA 01950-3867 | |
| (978) 463-1050 | |
| Not Available |
| Full Name | Pamela J Smith |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 28 Years |
| Location | 25 Highland Ave, Newburyport, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720031925 | NPI | - | NPPES |
| J21316 | Other | MA | BCBS OF MA |
| 3198758 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 40008 (Colorado) | Secondary |
| 207P00000X | Emergency Medicine | 160859 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lowell General Hospital | Lowell, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Circle Health Urgent Care Llc | 4486976792 | 31 |
News Archive
Getting older is a fact of life. Looking older doesn't have to be. Patients now have a non-invasive treatment option to reduce the signs of aging and fight wrinkles for good - with no downtime. Known for their use of the latest technological advancements, Dr. Gilbert Lee and his team at Changes Plastic Surgery & Spa are now using Artefill, the first and only FDA-approved microsphere-enhanced dermal filler for the correction of smile lines, or the lines from your nose to the corners of your mouth.
Lazarus Effect, a medical device company focused on the development of novel interventional devices to facilitate removal of blood clots, announced the closing of a $5 million financing. Proceeds from the financing will support EU commercialization of several approved Lazarus Effect devices, as well as regulatory filings for the Lazarus ReCover and Lazarus Cover in the United States.
Abbott today announced it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next-generation XIENCE PRIME Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
Survivors of cancer pay thousands of dollars in excess medical expenditures every year, with the excess financial burden varying by age and cancer site, according to a new American Cancer Society study. The study, appearing early online in the Journal of the National Cancer Institute, says targeted efforts will be important to reduce the economic burden of cancer.
As many as one in seven people will experience tinnitus, or ringing in their ears, at some time of their life, but not enough is being done to support patients who experience this distressing condition, according to an extensive research review in the November issue of the Journal of Clinical Nursing.
› Verified 7 days ago
| Entity Name | Circle Health Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710392683 PECOS PAC ID: 4486976792 Enrollment ID: O20141122000076 |
News Archive
Getting older is a fact of life. Looking older doesn't have to be. Patients now have a non-invasive treatment option to reduce the signs of aging and fight wrinkles for good - with no downtime. Known for their use of the latest technological advancements, Dr. Gilbert Lee and his team at Changes Plastic Surgery & Spa are now using Artefill, the first and only FDA-approved microsphere-enhanced dermal filler for the correction of smile lines, or the lines from your nose to the corners of your mouth.
Lazarus Effect, a medical device company focused on the development of novel interventional devices to facilitate removal of blood clots, announced the closing of a $5 million financing. Proceeds from the financing will support EU commercialization of several approved Lazarus Effect devices, as well as regulatory filings for the Lazarus ReCover and Lazarus Cover in the United States.
Abbott today announced it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next-generation XIENCE PRIME Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
Survivors of cancer pay thousands of dollars in excess medical expenditures every year, with the excess financial burden varying by age and cancer site, according to a new American Cancer Society study. The study, appearing early online in the Journal of the National Cancer Institute, says targeted efforts will be important to reduce the economic burden of cancer.
As many as one in seven people will experience tinnitus, or ringing in their ears, at some time of their life, but not enough is being done to support patients who experience this distressing condition, according to an extensive research review in the November issue of the Journal of Clinical Nursing.
› Verified 7 days ago
| Entity Name | Mass General Brigham Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891112637 PECOS PAC ID: 1759273436 Enrollment ID: O20150723007726 |
News Archive
Getting older is a fact of life. Looking older doesn't have to be. Patients now have a non-invasive treatment option to reduce the signs of aging and fight wrinkles for good - with no downtime. Known for their use of the latest technological advancements, Dr. Gilbert Lee and his team at Changes Plastic Surgery & Spa are now using Artefill, the first and only FDA-approved microsphere-enhanced dermal filler for the correction of smile lines, or the lines from your nose to the corners of your mouth.
Lazarus Effect, a medical device company focused on the development of novel interventional devices to facilitate removal of blood clots, announced the closing of a $5 million financing. Proceeds from the financing will support EU commercialization of several approved Lazarus Effect devices, as well as regulatory filings for the Lazarus ReCover and Lazarus Cover in the United States.
Abbott today announced it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next-generation XIENCE PRIME Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
Survivors of cancer pay thousands of dollars in excess medical expenditures every year, with the excess financial burden varying by age and cancer site, according to a new American Cancer Society study. The study, appearing early online in the Journal of the National Cancer Institute, says targeted efforts will be important to reduce the economic burden of cancer.
As many as one in seven people will experience tinnitus, or ringing in their ears, at some time of their life, but not enough is being done to support patients who experience this distressing condition, according to an extensive research review in the November issue of the Journal of Clinical Nursing.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pamela J Smith, MD 12 Gill St, Woburn, MA 01801-1728 Ph: (781) 937-4522 | Pamela J Smith, MD 25 Highland Ave, Newburyport, MA 01950-3867 Ph: (978) 463-1050 |
News Archive
Getting older is a fact of life. Looking older doesn't have to be. Patients now have a non-invasive treatment option to reduce the signs of aging and fight wrinkles for good - with no downtime. Known for their use of the latest technological advancements, Dr. Gilbert Lee and his team at Changes Plastic Surgery & Spa are now using Artefill, the first and only FDA-approved microsphere-enhanced dermal filler for the correction of smile lines, or the lines from your nose to the corners of your mouth.
Lazarus Effect, a medical device company focused on the development of novel interventional devices to facilitate removal of blood clots, announced the closing of a $5 million financing. Proceeds from the financing will support EU commercialization of several approved Lazarus Effect devices, as well as regulatory filings for the Lazarus ReCover and Lazarus Cover in the United States.
Abbott today announced it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next-generation XIENCE PRIME Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
Survivors of cancer pay thousands of dollars in excess medical expenditures every year, with the excess financial burden varying by age and cancer site, according to a new American Cancer Society study. The study, appearing early online in the Journal of the National Cancer Institute, says targeted efforts will be important to reduce the economic burden of cancer.
As many as one in seven people will experience tinnitus, or ringing in their ears, at some time of their life, but not enough is being done to support patients who experience this distressing condition, according to an extensive research review in the November issue of the Journal of Clinical Nursing.
› Verified 7 days ago
John Mclaulin, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25 Highland Ave, Newburyport, MA 01950 Phone: 978-463-1050 | |
Dr. Bethany A Bishop Daniels, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 25 Highland Ave, Anna Jaques Hospital- Emergency Dept, Newburyport, MA 01950 Phone: 978-463-1050 | |
Dr. Michelle R Laflamme, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 25 Highland Ave, Newburyport, MA 01950 Phone: 978-463-1050 | |
Doron E. Korinow, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 25 Highland Ave, Newburyport, MA 01950 Phone: 978-463-1000 | |
Dr. Alana Hirsh, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 25 Highland Ave, (anna Jaques Hospital, Emergency Department), Newburyport, MA 01950 Phone: 978-463-1000 | |
Dr. Andrew Sclar, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 25 Highland Ave, Newburyport, MA 01950 Phone: 978-463-1050 | |
Jon Jenkins, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 25 Highland Ave, Newburyport, MA 01950 Phone: 978-463-1050 |